+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Interventional Cardiology Devices Market Size, Share & Trends Analysis Report by Product (Coronary Stents, PTCA Balloon Catheters, Intravascular Imaging Catheters and Pressure Guidewires, Accessory Devices), by Region, and Segment Forecasts, 2025-2033

  • PDF Icon

    Report

  • 150 Pages
  • August 2025
  • Region: Global
  • Grand View Research
  • ID: 5899629
The global interventional cardiology devices market size was estimated at USD 10.57 billion in 2024 and is projected to reach USD 19.75 billion by 2033, growing at a CAGR of 7.25% from 2025 to 2033. The market growth is driven by the rising prevalence of cardiovascular diseases, increased demand for minimally invasive procedures, and technological advancements such as drug-eluting stents and bioresorbable vascular scaffolds.

The expanding elderly population, rising healthcare spending, and improved access to cardiac care in emerging markets also contribute to market expansion. Product innovation and integration of AI and imaging in catheter-based interventions further fuel demand. The rising prevalence of cardiovascular diseases is a primary market driver. Sedentary lifestyles, poor dietary habits, and increasing rates of obesity and diabetes have led to a global surge in coronary artery disease and other cardiac conditions. This growing disease burden has increased the demand for timely and effective interventions, boosting the adoption of stents, catheters, and other interventional tools.

In October 2024, the CDC reported that heart disease continues to be the top cause of death in the U.S., responsible for more than 919,000 deaths in 2023, or roughly one-third of all fatalities. A person dies from cardiovascular disease every 34 seconds, and around 5% of adults are affected by coronary artery disease. Between 2020 and 2021, heart disease incurred a financial toll of USD 417.9 billion in healthcare costs, medications, and lost productivity.

Global Interventional Cardiology Devices Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country-level and provides an analysis of the latest industry trends in each of the sub-segments from 2021-2033. The analyst has segmented the global Interventional cardiology devices market report based on product and region:

Product Outlook (Revenue, USD Million, 2021-2033)

  • Coronary Stents
  • DES
  • BMS
  • BRS
  • PTCA Balloon Catheters
  • Normal
  • Specialty
  • Drug-Coated
  • Intravascular Imaging Catheters and Pressure Guidewires
  • Accessory Devices
  • PTCA Guidewires
  • PTCA Guiding Catheters
  • Introducer Sheaths

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Sweden
  • Denmark
  • Norway
  • Asia-Pacific
  • China
  • India
  • Japan
  • Thailand
  • South Korea
  • Australia
  • Latin America
  • Brazil
  • Argentina
  • MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segmental and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.3. Competitive Insights
Chapter 3. Global Interventional Cardiology Devices Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Global Interventional Cardiology Devices: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
3.4. Technology Landscape
3.5. Case Study Analysis
Chapter 4. Global Interventional Cardiology Devices Market Segment Analysis, by Product, 2021-2033 (USD Million)
4.1. Definition and Scope
4.2. Product Market Share Analysis, 2024 & 2033
4.3. Segment Dashboard
4.4. Global Interventional Cardiology Devices Market, by Product, 2021-2033
4.5. Coronary Stents
4.5.1. Coronary stents market estimates and forecasts, 2021-2033 (USD Million)
4.5.2. DES
4.5.2.1. DES market estimates and forecasts, 2021-2033 (USD Million)
4.5.3. BMS
4.5.3.1. BMS market estimates and forecasts, 2021-2033 (USD Million)
4.5.4. BRS
4.5.4.1. BRS market estimates and forecasts, 2021-2033 (USD Million)
4.6. PTCA Balloon Catheters
4.6.1. PTCA balloon catheters market estimates and forecasts, 2021-2033 (USD Million)
4.6.2. Normal
4.6.2.1. Normal market estimates and forecasts, 2021-2033 (USD Million)
4.6.3. Specialty
4.6.3.1. Specialty market estimates and forecasts, 2021-2033 (USD Million)
4.6.4. Drug-Coated
4.6.4.1. Drug-coated market estimates and forecasts, 2021-2033 (USD Million)
4.7. Intravascular Imaging Catheters and Pressure Guidewires
4.7.1. Intravascular imaging catheters and pressure guidewires market estimates and forecasts, 2021-2033 (USD Million)
4.8. Accessory devices
4.8.1. Accessory devices market estimates and forecasts, 2021-2033 (USD Million)
4.8.2. PTCA Guidewires
4.8.2.1. PTCA guidewires market estimates and forecasts, 2021-2033 (USD Million)
4.8.3. PTCA Guiding Catheters
4.8.3.1. PTCA guiding catheters market estimates and forecasts, 2021-2033 (USD Million)
4.8.4. Introducer Sheaths
4.8.4.1. Introducer sheaths market estimates and forecasts, 2021-2033 (USD Million)
Chapter 5. Interventional Cardiology Devices Market Segment Analysis, by Region, 2021-2033 (USD Million)
5.1. Regional Market Share Analysis, 2024 & 2034
5.2. Regional Market Dashboard
5.3. Regional Market Snapshot
5.4. Interventional Cardiology Devices Market Share by Region, 2024 & 2033:
5.5. North America
5.5.1. North America Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.5.2. U.S.
5.5.2.1. Key Country Dynamics
5.5.2.2. Regulatory Scenario
5.5.2.3. Competitive Scenario
5.5.2.4. U.S. Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.5.3. Canada
5.5.3.1. Key Country Dynamics
5.5.3.2. Regulatory Scenario
5.5.3.3. Competitive Scenario
5.5.3.4. Canada Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.5.4. Mexico
5.5.4.1. Key Country Dynamics
5.5.4.2. Regulatory Scenario
5.5.4.3. Competitive Scenario
5.5.4.4. Mexico Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.6. Europe
5.6.1. Europe Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.6.2. UK
5.6.2.1. Key Country Dynamics
5.6.2.2. Regulatory Scenario
5.6.2.3. Competitive Scenario
5.6.2.4. UK Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.6.3. Germany
5.6.3.1. Key Country Dynamics
5.6.3.2. Regulatory Scenario
5.6.3.3. Competitive Scenario
5.6.3.4. Germany Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.6.4. France
5.6.4.1. Key Country Dynamics
5.6.4.2. Regulatory Scenario
5.6.4.3. Competitive Scenario
5.6.4.4. France Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.6.5. Italy
5.6.5.1. Key Country Dynamics
5.6.5.2. Regulatory Scenario
5.6.5.3. Competitive Scenario
5.6.5.4. Italy Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.6.6. Spain
5.6.6.1. Key Country Dynamics
5.6.6.2. Regulatory Scenario
5.6.6.3. Competitive Scenario
5.6.6.4. Spain Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.6.7. Norway
5.6.7.1. Key Country Dynamics
5.6.7.2. Regulatory Scenario
5.6.7.3. Competitive Scenario
5.6.7.4. Norway Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.6.8. Sweden
5.6.8.1. Key Country Dynamics
5.6.8.2. Regulatory Scenario
5.6.8.3. Competitive Scenario
5.6.8.4. Sweden Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.6.9. Denmark
5.6.9.1. Key Country Dynamics
5.6.9.2. Regulatory Scenario
5.6.9.3. Competitive Scenario
5.6.9.4. Denmark Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.7. Asia-Pacific
5.7.1. Japan
5.7.1.1. Key Country Dynamics
5.7.1.2. Regulatory Scenario
5.7.1.3. Competitive Scenario
5.7.1.4. Japan Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.7.2. China
5.7.2.1. Key Country Dynamics
5.7.2.2. Regulatory Scenario
5.7.2.3. Competitive Scenario
5.7.2.4. China Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.7.3. India
5.7.3.1. Key Country Dynamics
5.7.3.2. Regulatory Scenario
5.7.3.3. Competitive Scenario
5.7.3.4. India Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.7.4. Australia
5.7.4.1. Key Country Dynamics
5.7.4.2. Regulatory Scenario
5.7.4.3. Competitive Scenario
5.7.4.4. Australia Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.7.5. South Korea
5.7.5.1. Key Country Dynamics
5.7.5.2. Regulatory Scenario
5.7.5.3. Competitive Scenario
5.7.5.4. South Korea Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.7.6. Thailand
5.7.6.1. Key Country Dynamics
5.7.6.2. Regulatory Scenario
5.7.6.3. Competitive Scenario
5.7.6.4. Thailand Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.8. Latin America
5.8.1. Brazil
5.8.1.1. Key Country Dynamics
5.8.1.2. Regulatory Scenario
5.8.1.3. Competitive Scenario
5.8.1.4. Brazil Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.8.2. Argentina
5.8.2.1. Key Country Dynamics
5.8.2.2. Regulatory Scenario
5.8.2.3. Competitive Scenario
5.8.2.4. Argentina Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.9. MEA
5.9.1. South Africa
5.9.1.1. Key Country Dynamics
5.9.1.2. Regulatory Scenario
5.9.1.3. Competitive Scenario
5.9.1.4. South Africa Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.9.2. Saudi Arabia
5.9.2.1. Key Country Dynamics
5.9.2.2. Regulatory Scenario
5.9.2.3. Competitive Scenario
5.9.2.4. Saudi Arabia Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.9.3. UAE
5.9.3.1. Key Country Dynamics
5.9.3.2. Regulatory Scenario
5.9.3.3. Competitive Scenario
5.9.3.4. UAE Interventional Cardiology Devices Market, 2021-2033 (USD Million)
5.9.4. Kuwait
5.9.4.1. Key Country Dynamics
5.9.4.2. Regulatory Scenario
5.9.4.3. Competitive Scenario
5.9.4.4. Kuwait Interventional Cardiology Devices Market, 2021-2033 (USD Million)
Chapter 6. Competitive Landscape
6.1. Recent Developments & Impact Analysis, by Key Market Participants
6.2. Company Categorization
6.3. Company Profiles
6.3.1. Abbott
6.3.1.1. Company overview
6.3.1.2. Financial performance
6.3.1.3. Product benchmarking
6.3.1.4. Strategic initiatives
6.3.2. Medtronic plc
6.3.2.1. Company overview
6.3.2.2. Financial performance
6.3.2.3. Product benchmarking
6.3.2.4. Strategic initiatives
6.3.3. Boston Scientific Corporation
6.3.3.1. Company overview
6.3.3.2. Financial performance
6.3.3.3. Product benchmarking
6.3.3.4. Strategic initiatives
6.3.4. Cardinal Health, Inc.
6.3.4.1. Company overview
6.3.4.2. Financial performance
6.3.4.3. Product benchmarking
6.3.4.4. Strategic initiatives
6.3.5. Koninklijke Philips N.V.
6.3.5.1. Company overview
6.3.5.2. Financial performance
6.3.5.3. Product benchmarking
6.3.5.4. Strategic initiatives
6.3.6. Terumo Corporation
6.3.6.1. Company overview
6.3.6.2. Financial performance
6.3.6.3. Product benchmarking
6.3.6.4. Strategic initiatives
6.3.7. Alvimedica Medical Technologies Inc.
6.3.7.1. Company overview
6.3.7.2. Financial performance
6.3.7.3. Product benchmarking
6.3.7.4. Strategic initiatives
6.3.8. Teleflex Incorporated
6.3.8.1. Company overview
6.3.8.2. Financial performance
6.3.8.3. Product benchmarking
6.3.8.4. Strategic initiatives
6.3.9. B. Braun Melsungen AG
6.3.9.1. Company overview
6.3.9.2. Financial performance
6.3.9.3. Product benchmarking
6.3.9.4. Strategic initiatives
6.3.10. Biosensors International Group, Ltd.
6.3.10.1. Company overview
6.3.10.2. Financial performance
6.3.10.3. Product benchmarking
6.3.10.4. Strategic initiatives
6.3.11. Meril Life Sciences Pvt. Ltd.
6.3.11.1. Company overview
6.3.11.2. Financial performance
6.3.11.3. Product benchmarking
6.3.11.4. Strategic initiatives
6.3.12. BIOTRONIK SE & Co. KG.
6.3.12.1. Company overview
6.3.12.2. Financial performance
6.3.12.3. Product benchmarking
6.3.12.4. Strategic initiatives
6.3.13. ACIST Medical Systems, Inc.
6.3.13.1. Company overview
6.3.13.2. Financial performance
6.3.13.3. Product benchmarking
6.3.13.4. Strategic initiatives
6.3.14. Asahi Intecc Co., Ltd.
6.3.14.1. Company overview
6.3.14.2. Financial performance
6.3.14.3. Product benchmarking
6.3.14.4. Strategic initiatives
6.3.15. Cook Medical LLC
6.3.15.1. Company overview
6.3.15.2. Financial performance
6.3.15.3. Product benchmarking
6.3.15.4. Strategic initiatives
6.3.16. Medinol Ltd.
6.3.16.1. Company overview
6.3.16.2. Financial performance
6.3.16.3. Product benchmarking
6.3.16.4. Strategic initiatives
6.3.17. Merit Medical Systems, Inc.
6.3.17.1. Company overview
6.3.17.2. Financial performance
6.3.17.3. Product benchmarking
6.3.17.4. Strategic initiatives
6.3.18. NuMED, Inc.
6.3.18.1. Company overview
6.3.18.2. Financial performance
6.3.18.3. Product benchmarking
6.3.18.4. Strategic initiatives
6.3.19. OpSens Inc.
6.3.19.1. Company overview
6.3.19.2. Financial performance
6.3.19.3. Product benchmarking
6.3.19.4. Strategic initiatives
6.3.20. Zeon Medical Inc.
6.3.20.1. Company overview
6.3.20.2. Financial performance
6.3.20.3. Product benchmarking
6.3.20.4. Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 North America Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 4 U.S. Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 5 Canada Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 6 Mexico Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 7 Europe Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 8 UK Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 9 Germany Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 10 France Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 11 Italy Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 12 Spain Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 13 Sweden Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 14 Denmark Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 15 Norway Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 16 Asia-Pacific Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 17 Japan Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 18 China Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 19 India Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 20 Australia Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 21 South Korea Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 22 Thailand Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 23 Latin America Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 24 Brazil Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 25 Argentina Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 26 MEA Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 27 South Africa Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 28 Saudi Arabia Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 29 UAE Interventional cardiology devices market, by product, 2021-2033 (USD Million)
Table 30 Kuwait Interventional cardiology devices market, by product, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Interventional cardiology devices: market outlook
Figure 9 Interventional cardiology devices competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook.
Figure 12 Interventional cardiology devices driver impact
Figure 13 Interventional cardiology devices restraint impact
Figure 14 Interventional cardiology devices strategic initiatives analysis
Figure 15 Interventional cardiology devices: Product movement analysis
Figure 16 Interventional cardiology devices: Product outlook and key takeaways
Figure 17 Coronary stents market estimates and forecasts, 2021-2033
Figure 18 DES market estimates and forecasts, 2021-2033
Figure 19 BMS market estimates and forecasts, 2021-2033
Figure 20 BRS market estimates and forecasts, 2021-2033
Figure 21 PTCA balloon catheters market estimates and forecasts, 2021-2033
Figure 22 Normal market estimates and forecasts, 2021-2033
Figure 23 Specialty market estimates and forecasts, 2021-2033
Figure 24 Drug-coated market estimates and forecasts, 2021-2033
Figure 25 Intravascular imaging catheters and pressure guidewires market estimates and forecasts, 2021-2033
Figure 26 Accessory devices market estimates and forecasts, 2021-2033
Figure 27 PTCA guidewires market estimates and forecasts, 2021-2033
Figure 28 PTCA guiding catheters market estimates and forecasts, 2021-2033
Figure 29 Introducer sheaths market estimates and forecasts, 2021-2033
Figure 30 Global Interventional cardiology devices market: Regional movement analysis
Figure 31 Global Interventional cardiology devices market: Regional outlook and key takeaways
Figure 32 North America Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 33 Key country dynamics
Figure 34 U.S. Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 35 Key country dynamics
Figure 36 Canada Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 37 Key country dynamics
Figure 38 Mexico Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 39 Europe Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 40 Key country dynamics
Figure 41 UK Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 42 Key country dynamics
Figure 43 Germany Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 44 Key country dynamics
Figure 45 Spain Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 46 Key country dynamics
Figure 47 France Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 48 Key country dynamics
Figure 49 Italy Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 50 Key country dynamics
Figure 51 Norway Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 52 Key country dynamics
Figure 53 Denmark Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 54 Key country dynamics
Figure 55 Sweden Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 56 Asia-Pacific Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 57 Key country dynamics
Figure 58 Japan Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 59 Key country dynamics
Figure 60 China Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 61 Key country dynamics
Figure 62 India Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 63 Key country dynamics
Figure 64 Australia Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 65 Key country dynamics
Figure 66 South Korea Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 67 Key country dynamics
Figure 68 Thailand Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 69 Latin America Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 70 Key country dynamics
Figure 71 Brazil Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 72 Key country dynamics
Figure 73 Mexico Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 74 Key country dynamics
Figure 75 Argentina Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 76 MEA Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 77 Key country dynamics
Figure 78 South Africa Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 79 Key country dynamics
Figure 80 Saudi Arabia Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 81 Key country dynamics
Figure 82 UAE Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)
Figure 83 Key country dynamics
Figure 84 Kuwait Interventional cardiology devices market estimates and forecasts, 2021-2033 (USD Million)

Companies Mentioned

The major companies profiled in this Interventional Cardiology Devices market report include:
  • Abbott
  • Medtronic plc
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Koninklijke Philips N.V.
  • Terumo Corporation
  • Alvimedica Medical Technologies Inc.
  • Teleflex Incorporated
  • B. Braun Melsungen AG
  • Biosensors International Group, Ltd.
  • Meril Life Sciences Pvt. Ltd.
  • BIOTRONIK SE & Co. KG
  • ACIST Medical Systems, Inc.
  • Asahi Intecc Co., Ltd.
  • Cook Medical LLC
  • Medinol Ltd.
  • Merit Medical Systems, Inc.
  • NuMED, Inc.
  • OpSens Inc.
  • Zeon Medical Inc.

Table Information